N@N

Market Maker Surveillance Report. FCEL, CLSD, FOLD, TXMD, BPMC, PZRX, Losing Stocks With Lowest Price Friction For Tuesday, No

^{Published on 2016-11-29 18:46:44 - WOPRAI}
 

November 29, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5693 companies with "abnormal" market making, 2742 companies with positive Friction Factors and 3144 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. FuelCell Energy Inc. (NASDAQ:FCEL), Clearside Biomedical (NASDAQ:CLSD), Amicus Therapeutics Inc. (NASDAQ:FOLD), TherapeuticsMD Inc. (NYSE:TXMD), Blueprint Medicines Corporation (NASDAQ:BPMC), PhaseRx (NASDAQ:PZRX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  FCEL    $-0.390   -0.14%    676,763      29.48%    1,334,955    58.14%    -658,192     -16,877 
  CLSD    $-3.330   -0.15%    33,597       27.74%    40,270       33.25%    -6,673       -20     
  FOLD    $-1.800   -0.22%    4,523,558    36.74%    4,996,294    40.57%    -472,736     -2,626  
  TXMD    $-1.070   -0.16%    6,432,322    36.78%    7,307,974    41.79%    -875,652     -8,184  
  BPMC    $-5.150   -0.15%    113,522      25.42%    177,994      39.85%    -64,472      -125    
  PZRX    $-0.620   -0.22%    1,197,947    37.31%    1,238,142    38.57%    -40,195      -648    

For example, the chart above shows FCEL with a dollar loss Tuesday of $-0.39000 and a Friction Factor of -16,877 shares. That means that it only took 16,877 more shares of selling than buying to move FCEL lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

FuelCell Energy Inc. (NASDAQ:FCEL) - FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed power generation. The company is also involved in the development, design, production, construction, and servicing of fuel cell products under the Direct FuelCell name. Its power plants electrochemically produce electricity and heat using various fuels, including natural gas, biogas, methanol, diesel, coal gas, coal mine methane, and propane. The company serves utilities, independent power producers, and governments; and education and healthcare, gas transmission, industrial and data centers, commercial and hospitality, oil production and refining, wastewater treatment, food and beverage, agriculture, and landfill gas sectors. It has an installed base and backlog of approximately 300 megawatts. The company operates in the United States, South Korea, England, Germany, Canada, and Spain. It has strategic alliances with NRG Energy; POSCO Energy Co., Ltd.; The Fraunhofer Institute for Ceramic Technologies and Systems; and E.ON Connecting Energies GmbH. The company was founded in 1969 and is headquartered in Danbury, Connecticut..

Clearside Biomedical (NASDAQ:CLSD) - CALSTAR INC.

Amicus Therapeutics Inc. (NASDAQ:FOLD) - Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical study for the treatment of the genetic connective tissue disorder epidermolysis bullosa; ATB200 that is in Phase II studies to treat pompe disease; AT2221, which is in Phase II studies for the treatment of pompe disease; and AT3375 to treat Parkinson's disease. The company has strategic alliance with GlaxoSmithKline plc to develop and commercialize migalastat as a monotherapy and in combination with ERT for Fabry disease. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey..

TherapeuticsMD Inc. (NYSE:TXMD) - .

Blueprint Medicines Corporation (NASDAQ:BPMC) - .

PhaseRx (NASDAQ:PZRX) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net